Compare GIS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIS | WST |
|---|---|---|
| Founded | 1866 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 20.2B |
| IPO Year | N/A | N/A |
| Metric | GIS | WST |
|---|---|---|
| Price | $46.95 | $275.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | $53.40 | ★ $345.75 |
| AVG Volume (30 Days) | ★ 7.0M | 691.8K |
| Earning Date | 12-17-2025 | 02-12-2026 |
| Dividend Yield | ★ 5.19% | 0.32% |
| EPS Growth | ★ 0.65 | 0.17 |
| EPS | 4.63 | ★ 6.75 |
| Revenue | ★ $18,776,700,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ $10.17 | $40.63 |
| Revenue Growth | N/A | ★ 4.92 |
| 52 Week Low | $45.15 | $187.43 |
| 52 Week High | $67.35 | $348.90 |
| Indicator | GIS | WST |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 53.35 |
| Support Level | $46.45 | $264.92 |
| Resistance Level | $49.25 | $279.01 |
| Average True Range (ATR) | 0.75 | 6.05 |
| MACD | 0.03 | 0.64 |
| Stochastic Oscillator | 38.88 | 79.65 |
General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.